Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Early cancer screening

07.05.2003


A EUREKA funded project is making real progress in the fight against cancer of the large intestine. One of the three most common cancer types in western countries, cancer of the large intestine is also one of the hardest to diagnose. In 50 per cent of cases it is detected too late to be successfully treated with surgery. But EUREKA project GENEFEC has developed a new test which could save thousands of lives by detecting early signs of the disease.

The new DNA-based test, developed by Norwegian company Nordiag and Berlin-based biotechnology firm Invitek GmbH, aims to identify patients with curable pre-cancerous cells in the colon, rectum and pancreas.

“There are a million new cases of colorectal cancer each year, causing around 450,000 deaths,” says Dr Dagfinn Ogreid of the Norsk Center for Gastro-Intestinal Cancerdiagnostikk. “If our test saves just 20% of these patients - and it could be as high as 50% - that’s a lot of lives saved.”



Doctors working in this area have relied upon invasive, time-consuming and painful endoscopic techniques to screen patients. The non-invasive alternative is faecal blood tests, but these tests are not traditionally cancer-specific and have successful detection rates as low as two per cent. Up to 98 per cent of patients are shown to have completely different conditions.

But GENEFEC’s Norwegian and German partners have used a gene which is known to spontaneously mutate in a cell of the gut lining up to five years before the cell becomes malignant, to form the basis of a new and improved faecal test. Nordiag’s Dr Oegreid has developed a method of detecting this mutation using the polymerase chain reaction technique to magnify fragments of DNA shed in the patient’s faeces.

The new test, which takes less than two hours, has attracted interest around the world and is now used by Norway’s public health service. “We have plans to open a laboratory in Berlin with our German partners,” says Dr Ogreid. “This will be an opportunity not only to get into the diagnostic market, but also to work towards our second goal: the robotisation of the tests, which will make the technique even quicker and more reliable.”

The test has enormous market potential. With a population of 4.5 million, Norway has about 4,000 new cases of colorectal cancer every year. There is a market for 20,000 tests a year in Norway alone if doctors screen everyone with a family history of the disease. This figure could rise to over 600,000 if everyone over 40 years old – the highest risk category – is screened. And its impact will of course be widened greatly if it is made available across Europe.

The two partners initially began working on similar technology independently. But when Nordiag scientists became aware that the German group was developing a similar method, it became clear that they could reach their goal faster by pooling their expertise. Dr Oegreid says EUREKA support has been vital to getting the project off the ground. “EUREKA opened doors that allowed us to obtain private sponsorship from insurance companies to fund our research.”

Nicola Vatthauer | alfa
Further information:
http://www.eureka.be/genefec

More articles from Health and Medicine:

nachricht Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Injecting gene cocktail into mouse pancreas leads to humanlike tumors
06.04.2018 | University of Texas Health Science Center at San Antonio

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>